As AI acquisitions have drawn more antitrust scrutiny, particularly deals involving companies already dominant in adjacent markets, the anticipated regulatory review process has started shaping how deals are structured well before they're publicly announced - a shaping that's largely invisible in coverage focused on the announcement itself.
How anticipated review shapes deal structure
Companies anticipating antitrust scrutiny sometimes structure a transaction as an investment with board influence rather than an outright acquisition, structure it to fall below regulatory reporting thresholds, or build in explicit carve-outs and independence provisions designed to preempt an anticipated objection - all decisions made before any public announcement, shaped by legal anticipation of a review that may never become visible if it succeeds in avoiding formal scrutiny.
Why this matters for reading acquisition announcements
An unusual deal structure - a large investment that stops short of full acquisition, an announcement emphasizing the target's continued independence - is sometimes a direct signal of anticipated regulatory concern, even when the announcement itself doesn't reference antitrust considerations at all.
Where this becomes visible after the fact
Regulatory filings, when they do occur, and any subsequent enforcement action provide the clearest confirmation of anticipated antitrust concerns, but by the time these become public, the deal's structure has often already been shaped around avoiding exactly that scrutiny.
What more complete acquisition coverage would ask
Why a deal was structured the way it was, specifically whether the structure appears designed to minimize regulatory review, is a question worth asking directly of the parties involved, even when - especially when - they don't volunteer the answer.